APLSNasdaqSEC EDGAREDGAR

Apellis Pharmaceuticals, Inc.

Pharmaceutical Preparations·WALTHAM, MA·FY end 12/31·CIK 1492422

Board of Directors

8 members · 7 independent · FY 2024
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Gerald ChanChair12y74NCG—
Cedric FrancoisCEO and Director16y52———
Paul FonteyneDirector5y63AuditCompCompliance—
Stephanie Monaghan O'BrienDirector12y66CompNCGCompliance—
A. Sinclair DunlopDirector15y53AuditNCG—
Alec MachielsDirector16y52AuditCompCompliance—
Keli WalbertDirector1y58CompComplianceNCG—
Craig WheelerDirector1y63Audit—

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.